TP53 and cancer: Previous studies have suggested that Linc-ROR significantly inhibited p53 in the process of DNA damage, thereby affecting the arrest and apoptosis of cancer cells, which is believed to be the cause of resistance to platinum chemotherapy in cancer patients [24].